**Bottom line:** The CEO’s proposal is not legally defensible. The deck’s ARR and NRR figures are most likely **material misstatements of present or historical fact**, not protected projections. The CFO’s email is a serious scienter problem. The anchor investor has likely already become irrevocably committed, so a later correction will **not** cut off reliance for that investor; the company should offer rescission or a negotiated release. For the unsigned $32 million, a complete, timely corrected disclosure **before signing** can cut off reliance under the supplied rules, but only if the disclosure is complete and specifically addresses the true ARR, the true retention figure, the prior nonstandard metric, and the customer non-renewal. The founder’s secondary must be frozen and likely pulled unless every buyer receives the corrected nonpublic information before the secondary proceeds. The board should reject the CEO’s plan, adopt corrective resolutions, suspend closing, remediate the anchor position, and then negotiate a reprice or restructure on a corrected basis.

---

## 1. Whether the ARR and retention figures are misstatements of present fact or protected projections

### A. The $14.2 million ARR figure

The deck states:

> “ARR: $14.2M.”

That is not, on the facts given, a forward-looking statement. ARR is ordinarily a point-in-time operating metric: annualized recurring revenue. The deck presents $14.2 million as the company’s current ARR, not as a forecast, target, or “pipeline-adjacent” projection.

The diligence work shows that the $14.2 million figure includes:

1. **$2.6 million of one-time implementation-services fees**  
   One-time services fees are not recurring subscription revenue. Including them in ARR is not a standard ARR calculation.

2. **A $1.1 million contract that is signed but not yet live and is terminable by the customer on 60 days’ notice before go-live**  
   This is at best a pipeline or committed-but-not-yet-live item. Because the customer may terminate before go-live, it is not safe to treat as current recurring ARR. On a standard recurring-subscription basis, ARR is approximately **$10.5 million**.

Thus, there are two independent problems:

* If the company meant standard ARR, the statement “ARR: $14.2M” is **untrue**.
* If the company meant some broader, nonstandard “pipeline-adjacent” metric, the deck fails to disclose the material fact that the number includes one-time fees and a signed-but-not-live, terminable contract. Under the supplied rules, an **omission of a material fact necessary to make the statement not misleading** is also unlawful.

The figure therefore should be treated as a **misstatement of present or historical fact**, not a protected forward-looking statement.

### B. The 138% net revenue retention figure

The deck states:

> “Net revenue retention: 138%.”

The facts state that the 138% figure was computed on a customer cohort that **excludes the two largest accounts lost during the year**. Including them, retention is **111%**.

This is also a present or historical metric, not a projection. It is calculated from actual prior-period customer behavior. The key issue is the cohort selection. Excluding the two largest lost accounts from the NRR calculation is not a neutral definitional choice; it materially overstates the quality of the existing customer base. A reasonable investor would consider the full-cohort figure important.

So the NRR figure has the same problem as ARR:

* If the company meant standard NRR, “Net revenue retention: 138%” is **untrue**.
* If the company meant a nonstandard, cherry-picked cohort, the deck omits a material fact necessary to make the statement not misleading.

The corrected figure should be **111%**, or at minimum the company must disclose the cohort definition and why the two largest lost accounts were excluded. But on the facts, the 138% number is materially misleading.

### C. The final-slide disclaimer does not protect the numbers

The deck’s final slide contains a general disclaimer that projections “involve risks and uncertainties.”

That disclaimer fails for several reasons under the supplied rules:

1. **The ARR and NRR numbers are not projections.**  
   The protection for projections and forward-looking statements does not extend to misstatements of present or historical fact.

2. **The disclaimer is boilerplate.**  
   The supplied rules state that boilerplate cautions are not meaningful. “Involves risks and uncertainties” is generic and does not identify the specific risks here:
   * inclusion of one-time implementation fees;
   * inclusion of a signed-but-not-live contract;
   * the customer’s 60-day termination right before go-live;
   * exclusion of the two largest lost accounts from NRR;
   * customer concentration;
   * the recent non-renewal notice.

3. **The disclaimer does not make the numbers forward-looking.**  
   Labeling a projection as “forward-looking” is not enough if the company has misrepresented present facts. The numbers were presented as current metrics.

Accordingly, the general disclaimer provides **no meaningful protection** for the ARR or NRR statements.

---

## 2. Materiality: quantifying the gaps and assessing them against the total-mix standard

### A. Quantified metric gaps

| Metric | Deck figure | Correct figure | Gap | Relative size |
|---|---:|---:|---:|---:|
| ARR | $14.2M | $10.5M | $3.7M | 26.1% of stated ARR; 35.2% of correct ARR |
| One-time implementation fees included | $2.6M | $0 in standard ARR | $2.6M | 18.3% of stated ARR |
| Signed-but-not-live, terminable contract included | $1.1M | $0 in current standard ARR | $1.1M | 7.7% of stated ARR |
| Net revenue retention | 138% | 111% | 27 percentage points | 24.3% relative overstatement |
| Non-renewal notice | not disclosed | 9% of subscription revenue | approx. $0.945M ARR | 9% of correct subscription ARR |

The $3.7 million ARR overstatement is not a trivial rounding issue. It is more than a quarter of the stated ARR. For a Series B priced at a $220 million pre-money valuation, the metric gap is especially significant.

Using only the multiple embedded in the deal:

* Stated ARR: $14.2M  
  Implied multiple: $220M / $14.2M ≈ **15.5x ARR**

* Corrected ARR: $10.5M  
  At the same multiple, implied valuation: $10.5M × 15.5 ≈ **$163M**  
  Implied valuation gap: roughly **$57M**, or about **26% of the stated pre-money valuation**.

* If the 9% customer non-renewal occurs, ARR falls from approximately $10.5M to approximately **$9.55M**.  
  At the same multiple, implied valuation: $9.55M × 15.5 ≈ **$148M**  
  Combined implied gap from stated ARR and non-renewal: roughly **$72M**, or about **33% of the stated pre-money valuation**.

This is an illustrative valuation bridge, not a definitive reprice, but it shows why the gaps are not immaterial. A reasonable investor would likely view the difference between $14.2M and $10.5M ARR, and between 138% and 111% NRR, as central to the investment decision.

### B. Materiality of the ARR overstatement

The ARR gap is material under the total-mix standard.

A reasonable investor in a SaaS Series B would consider:

* current recurring revenue;
* the quality and durability of that revenue;
* whether revenue is one-time, deferred, signed-but-not-live, or terminable;
* the relationship between ARR and valuation;
* whether management is using nonstandard metrics to present a stronger growth story.

Here, the company included $3.7 million of nonstandard revenue in ARR, increasing ARR by roughly 35% relative to the standard recurring figure. That is material on its face.

### C. Materiality of the NRR overstatement

The NRR gap is also material.

NRR is a core quality-of-growth metric in SaaS. The difference between 138% and 111% is not merely semantic:

* 138% suggests strong expansion from existing customers.
* 111% suggests growth, but far weaker expansion.
* The fact that the 138% figure excluded the two largest lost accounts makes the overstatement worse, because it removed the most significant churn from the calculation.

Even if the company argues that alternative NRR methodologies exist, the deck did not disclose the cohort selection. Under the supplied rules, the omission of that fact is material.

### D. Materiality of the customer non-renewal notice

Yesterday, Northgate’s second-largest subscription customer, representing **9% of subscription revenue**, delivered a non-renewal notice effective at term end in four months.

That notice is material for at least three reasons:

1. **Scale:**  
   Approximately 9% of subscription revenue, or roughly $0.945 million against the $10.5 million standard ARR figure, is at risk.

2. **Concentration:**  
   The customer is the second-largest subscription customer. Investor reliance on top-customer stability is high in SaaS.

3. **Timing and signaling:**  
   The notice occurred during the fundraising process, is nonpublic, and suggests possible deterioration in the customer base. It also compounds the NRR problem: the company had previously presented retention in a favorable way, and now a major customer is declining to renew.

Individually, a 9% customer non-renewal may be material. In the total mix, with the ARR and NRR overstatements and the CFO’s “keep the number” email, the non-renewal is clearly material.

### E. The CFO email increases the seriousness of the total mix

The CFO’s email says:

> “Everyone counts pipeline-adjacent. Keep the number. We can true it up after the round.”

That email is already in the diligence folder. It does more than show a definitional debate. It suggests that management knew the ARR metric was nonstandard, chose to keep the inflated number, and planned to address it after investors committed. In the total mix, that makes the metric overstatements more, not less, material.

A reasonable investor would consider it important that the company was aware the number was nonstandard and intended to “true it up after the round.”

---

## 3. Scienter: the effect of the CFO’s email and who is exposed

Under the supplied rules, liability requires **scienter**, which includes **recklessness**.

### A. The CFO’s email

The CFO’s email is a major problem.

It shows at least the following:

1. The CFO was asked about the ARR definition.
2. The CFO acknowledged that the company was using a nonstandard “pipeline-adjacent” measure.
3. The CFO decided to “keep the number.”
4. The CFO contemplated correcting it only after the round closed.

That is strong evidence of at least **reckless disregard** for the truth of the disclosure. The CFO need not have intended to defraud. Recklessness is enough.

The email also undercuts any argument that the inflated ARR was an innocent, industry-wide presentation choice. “Everyone counts pipeline-adjacent” is not a legally sufficient defense. The company must not make statements that are materially false or misleading, regardless of what others do.

### B. Company exposure

The company is exposed because it used the deck in connection with the sale of securities to investors.

The company made, or caused to be made, the statements:

* “ARR: $14.2M.”
* “Net revenue retention: 138%.”

Those statements are materially misleading on the facts. The company’s scienter can be inferred from the CFO’s email and the continued use of the deck after the definition issue was raised.

The company may face claims from:

* the anchor investor, which already wired $8 million;
* the $32 million of unsigned investors if they sign without receiving corrected disclosure;
* potentially purchasers of the founder’s secondary shares if they buy while the company and founder possess material nonpublic information.

### C. CFO exposure

The CFO is personally exposed.

The CFO is the author of the email. The CFO apparently knew or recklessly disregarded the fact that the ARR figure was nonstandard and that the NRR cohort was selectively constructed. The CFO may be liable to investors for the antifraud violations and may also face fiduciary or employment-related exposure depending on the board’s investigation.

The CFO should be advised to obtain separate counsel. The company’s counsel may not be able to represent both the company and the CFO if their interests diverge.

### D. CEO exposure

The CEO’s exposure depends on what the CEO knew and when.

If the CEO did not know of the ARR/NRR issues until this week, the CEO may not have personal scienter for the earlier use of the deck. But the facts make that difficult:

* The CEO proposes to “sign on schedule” and “fix the metrics deck for the Series C.”
* That proposal suggests the CEO now knows or should know that the deck is misleading.
* If the CEO proceeds after being informed, the CEO may have acted recklessly or with deliberate indifference.

If the CEO was involved in preparing or approving the deck earlier, the CEO may also be exposed for the prior statements.

The CEO should be cautious. At this point, the CEO’s “the business is real” argument is legally irrelevant. The question is whether the company made material false or misleading statements in connection with the sale of securities, not whether the company has a real business.

### E. Directors’ exposure

The directors are exposed if they approve a financing known to rest on misleading materials.

Under the supplied rules:

* Directors owe a duty of candor to shareholders.
* Directors owe good-faith oversight of company disclosures.
* Approving a financing known to rest on misleading materials implicates loyalty, not merely care.

If the board is told that the deck is materially misleading and nevertheless approves the financing on the old terms, the board likely acts in bad faith or with reckless disregard. That is not a duty-of-care error that can be hidden behind exculpation; it implicates loyalty and candor.

Even if the directors were previously unaware, the moment counsel identifies the problem, the board has a duty to address it. Continuing on the CEO’s course after that warning creates personal exposure.

### F. Founder exposure

The founder is exposed in connection with the $4 million secondary sale.

The founder likely possesses material nonpublic information:

* the true ARR figure;
* the true NRR figure;
* the customer non-renewal notice;
* the CFO’s “keep the number” email, if known to the founder.

If the founder sells shares to incoming investors who do not have that information, the founder violates the supplied insider-trading/antifraud rule.

The founder should also obtain separate counsel, especially if the board is investigating management’s conduct.

---

## 4. The anchor investor’s wired $8 million

### A. The anchor is likely already irrevocably committed

The anchor investor:

* signed a subscription agreement two weeks ago;
* wired an $8 million first tranche;
* did so based on the deck.

Under the supplied reliance rule, correction before an investor becomes irrevocably committed can cut off reliance. Here, the anchor has already signed and paid. Unless the subscription agreement expressly permits withdrawal upon correction or contains a condition that has not occurred, the anchor should be treated as **irrevocably committed**.

The fact that the full round has not closed does not necessarily save the company. A signed subscription and payment of a first tranche are strong evidence that the investor has committed.

### B. What correction can and cannot do for the anchor

A corrected deck now will **not** cut off the anchor’s reliance on the old deck. It cannot erase the fact that the anchor signed and paid based on the misleading metrics.

Correction may help in limited ways:

* it may reduce future damages;
* it may show good faith;
* it may support a settlement;
* it may prevent further reliance for any unpaid portions, if any exist;
* it may be necessary to renegotiate terms.

But correction alone is not enough. The anchor may still have claims for:

* damages;
* rescission;
* breach of representations and warranties, if the subscription contains such reps;
* antifraud liability.

### C. The company’s options

The company has several options, but the legally safest approach is to be proactive.

#### Option 1: Correct, negotiate an amendment, and obtain a release

The company can provide the anchor with a corrected disclosure package and ask the anchor to:

* amend the subscription agreement;
* accept corrected metrics and possibly a reprice;
* release the company and related parties from claims arising from the pre-correction materials.

This may allow the round to continue with the anchor. But a mere amendment is not enough unless it includes a meaningful release.

A release should cover claims arising from:

* the prior ARR and NRR statements;
* the CFO email;
* the customer non-renewal notice;
* any other pre-correction disclosure defects.

#### Option 2: Offer rescission and return the $8 million

The company can offer to rescind the anchor’s subscription and return the $8 million, plus interest if appropriate.

This is the cleanest way to eliminate the anchor’s antifraud claim. The cost is that the company may lose the anchor and the $8 million. But that may be cheaper than a fraud claim, rescission plus damages, or a failed round.

#### Option 3: Proceed without remediation

This is not advisable. If the company proceeds on the old terms without correcting the anchor’s position, the anchor may later rescind or sue for damages. The CFO email in the diligence folder makes that risk high.

### D. Whether rescission should be offered

Yes. The company should offer rescission as a voluntary option, or at minimum be prepared to do so if the anchor does not accept corrected terms and a release.

The offer should be made promptly, through counsel, and in writing. It should be clear that the company is correcting material inaccuracies and providing a full disclosure of the non-renewal.

If the anchor chooses to remain, the company should require:

* a written acknowledgment of the corrected disclosure;
* an amended subscription agreement;
* a release of claims;
* any appropriate price adjustment.

If the anchor chooses rescission, the company should return the funds promptly and document the release.

---

## 5. The unsigned $32 million: correction before signing

### A. What correction before signing accomplishes

Under the supplied rules, correction of a misstatement before an investor becomes irrevocably committed can cut off reliance for that investor.

For the $32 million that is committed by term sheet but not yet signed, a complete corrected disclosure delivered before signing should cut off reliance for those investors, provided:

1. the investors have not already become irrevocably committed;
2. the corrected disclosure is complete;
3. the corrected disclosure is specific and not buried;
4. the investors receive it before signing;
5. the old deck is clearly marked as superseded;
6. the investors acknowledge receipt.

There is a nuance: if a signed term sheet is binding and creates an irrevocable commitment, the reliance safe harbor may not be available for that investor even if the subscription agreement is unsigned. The company should check the term sheet. If the term sheet is binding, the company may need to amend or rescind the term sheet as well.

In any event, the company should not rely on a technical argument that the investors are “not yet committed.” The practical course is to deliver corrected disclosure before any signature and before any further binding commitment.

### B. What the corrected disclosure must contain

The corrected disclosure should be a stand-alone update, not a buried footnote. It should include, at minimum:

#### 1. Correction of ARR

The company should state:

> “Our prior deck stated ARR of $14.2 million. That figure used a nonstandard definition. It included $2.6 million of one-time implementation-services fees and a $1.1 million contract that was signed but not yet live and is terminable by the customer on 60 days’ notice before go-live. On a standard recurring-subscription basis, ARR is approximately $10.5 million.”

It should include a bridge:

* $14.2M prior reported ARR
* less $2.6M one-time implementation fees
* less $1.1M signed-but-not-live, terminable contract
* equals approximately $10.5M standard recurring ARR

#### 2. Correction of NRR

The company should state:

> “Our prior deck stated net revenue retention of 138%. That figure excluded the two largest accounts lost during the year. Including all customers in the relevant cohort, net revenue retention is 111%.”

It should disclose:

* the cohort used for the 138% figure;
* why the two largest lost accounts were excluded;
* the full-cohort 111% figure;
* the dollar or percentage impact of the lost accounts to the extent known.

#### 3. Customer non-renewal notice

The company must disclose the non-renewal. The disclosure should include:

* the fact of the non-renewal notice;
* that it was received yesterday;
* that the customer is the second-largest subscription customer;
* that the customer represents approximately 9% of subscription revenue;
* the effective date, i.e., term end in four months;
* the expected ARR impact, approximately $0.945 million based on current subscription ARR;
* any known efforts to renew, replace, or mitigate the loss, with specific cautionary language if forward-looking.

If customer confidentiality prevents naming the customer, the company can disclose the material facts without the name, but it cannot hide the significance.

#### 4. Explanation of the prior nonstandard metric

Because the CFO email is in the diligence folder and says “keep the number,” the company should not leave the prior metric unexplained. The corrected disclosure should state that the prior figure was nonstandard and has been restated. It does not necessarily need to quote the CFO’s email, but it should make clear that the company is correcting a metric that management had previously described as “pipeline-adjacent.”

The point is to avoid leaving investors with the impression that the company is quietly changing numbers without acknowledging the prior presentation.

#### 5. Updated financial information

The company should provide:

* updated income statement or revenue summary;
* updated cash flow if material;
* updated ARR schedule;
* updated retention schedule;
* customer concentration table;
* any material contract summaries, including the $1.1M contract and its termination right.

#### 6. Meaningful cautionary language for any projections

If the corrected deck includes forecasts, the cautions must be specific. Boilerplate is not enough.

Examples of meaningful cautions:

* “The $1.1 million contract is not included in current ARR because it is not yet live and is terminable by the customer on 60 days’s notice before go-live.”
* “Our projections assume the $1.1 million contract goes live and is not terminated. If the customer terminates before go-live, ARR will be lower.”
* “Our projections assume the second-largest customer non-renewal is not replaced. If it is replaced, ARR may be higher; if it is not replaced, ARR will decrease.”
* “Historical retention may not repeat, and customer concentration may lead to volatility.”
* “One-time implementation fees will not recur in the same amount.”

#### 7. Supersession and acknowledgment

The company should:

* mark the old deck as superseded;
* remove or annotate the old deck in the data room;
* provide the corrected deck as a stand-alone document;
* ask investors to acknowledge receipt;
* ensure the corrected disclosure is referenced in the subscription agreements and disclosure schedules.

### C. Effect of corrected disclosure for the $32 million

If the $32 million investors sign after receiving the complete corrected disclosure, their reliance should be on the corrected information. Under the supplied rules, that can cut off reliance for those investors.

This does not cure the anchor. It also does not cure any investor who has already become irrevocably committed through a binding term sheet or other obligation.

But for unsigned, non-binding investors, timely and complete corrected disclosure is the key protection.

---

## 6. The founder’s $4 million secondary sale

### A. The secondary may not proceed on the current facts

Under the supplied rules, a person who sells securities while in possession of material nonpublic information about the issuer, to a buyer without that information, violates the antifraud rules. The rule expressly includes founder secondary sales in a private financing.

The founder likely has material nonpublic information:

* the true ARR is approximately $10.5 million, not $14.2 million;
* the true NRR is 111%, not 138%;
* the second-largest customer has given non-renewal notice;
* the company is correcting a materially misleading fundraising deck.

The incoming investors do not have that information unless the company discloses it. Therefore, the founder’s $4 million secondary may not proceed while those buyers remain uninformed.

### B. Conditions under which the secondary could proceed

The secondary could proceed only if the information asymmetry is eliminated and the transaction is fair. Conditions should include:

1. **Full corrected disclosure to all buyers.**  
   Every investor receiving the founder’s shares must receive the corrected ARR, NRR, non-renewal notice, and related risk disclosures.

2. **No buyer remains in the dark.**  
   If some buyers know the corrected facts and others do not, the secondary to the uninformed buyers is prohibited.

3. **Anchor remediation is resolved.**  
   If the anchor is a purchaser of founder shares and has not been corrected and released, the secondary to that anchor should not proceed.

4. **Price adjustment.**  
   The secondary price should reflect the corrected metrics and the non-renewal. A secondary priced on the old $220 million pre-money valuation while the company corrects to materially weaker metrics would create serious fairness and fiduciary concerns.

5. **Board approval and conflict management.**  
   The founder is a principal. The board should ensure the secondary is approved by disinterested directors or an independent committee. If the founder is a director, the founder should recuse.

6. **No tipping or selective disclosure.**  
   The founder must not tip investors or allow some buyers to obtain the nonpublic information before others.

### C. If the conditions cannot be met, the secondary must be pulled

If the company cannot deliver corrected disclosure to all buyers before the secondary closes, the secondary must be suspended or withdrawn.

The board should adopt a formal freeze on the founder’s secondary sale until the conditions above are satisfied. This protects the company, the board, and the founder.

---

## 7. The board’s position if it follows the CEO’s proposal

The CEO proposes:

> “Sign on schedule. The business is real. We fix the metrics deck for the Series C.”

The board should reject this proposal.

### A. Candor and oversight

Under the supplied rules, directors owe:

* a duty of candor to shareholders;
* good-faith oversight of the company’s disclosures.

If the board is informed that the deck contains material misstatements and nevertheless approves the financing on the old terms, the board:

* fails its duty of candor;
* fails its disclosure oversight duty;
* approves a financing known to rest on misleading materials;
* implicates loyalty, not merely care.

The “business is real” argument does not cure the disclosure problem. A real business can still issue materially misleading fundraising materials.

The “fix it for Series C” plan makes the problem worse. It suggests an intention to conceal the corrected metrics from current investors and present different metrics to future investors. That is a classic scienter issue.

### B. Exculpation and insurance consequences

If the board proceeds knowingly:

1. **Exculpation is unlikely to protect directors.**  
   Exculpation generally protects against duty-of-care claims, not duty-of-loyalty, bad-faith, or fraud claims. Approving a financing known to be based on misleading materials is not a mere care failure.

2. **Indemnification will not cover adjudicated fraud.**  
   The supplied rules state that indemnification and D&O insurance do not cover liability finally adjudicated to arise from fraud.

3. **D&O insurance will likely deny coverage.**  
   Even if the policy contains an advancement provision, the company and directors should expect a coverage dispute. They should not rely on insurance for fraud-based liability.

4. **Directors face personal exposure.**  
   If the board proceeds after counsel’s warning, individual directors may face personal liability for breach of fiduciary duty and potentially antifraud exposure.

### C. What the board should do instead

The board should:

* reject the CEO’s proposal;
* direct immediate correction of the deck;
* suspend signing and closing;
* freeze the founder secondary;
* require anchor remediation;
* negotiate a reprice or restructure based on corrected metrics;
* document that it acted on counsel’s advice and in good faith.

Those steps protect the company and the directors far better than proceeding on the old deck.

---

## 8. The repricing conversation

### A. How to present the corrected metrics

The company should not try to talk investors out of the correction. The presentation should be direct:

1. **Lead with the correction, not the valuation.**  
   “We have identified material inaccuracies in the prior deck and are correcting them before signing.”

2. **Provide a clean bridge from the old numbers to the new numbers.**
   * $14.2M prior ARR
   * less $2.6M one-time fees
   * less $1.1M signed-but-not-live, terminable contract
   * equals approximately $10.5M standard ARR

3. **Explain the NRR correction.**
   * 138% excluded the two largest lost accounts.
   * 111% includes the full cohort.

4. **Disclose the non-renewal.**
   * second-largest customer;
   * 9% of subscription revenue;
   * effective in four months;
   * expected ARR impact.

5. **Do not minimize with “everyone counts.”**  
   The CFO email makes that phrase dangerous. The company should own the correction.

6. **Use specific cautionary language for any forward-looking statements.**  
   The company may present updated projections, but only with meaningful cautions about go-live risk, termination risk, non-renewal, replacement, and retention.

### B. Likely valuation impact

The original $220 million pre-money valuation implies approximately 15.5x the stated $14.2 million ARR.

On corrected ARR of $10.5 million, that same multiple implies approximately $163 million, not $220 million.

If the 9% non-renewal occurs, ARR falls to approximately $9.55 million, and the same multiple implies approximately $148 million.

The NRR correction from 138% to 111% may also pressure the multiple. NRR is a key driver of growth-quality pricing. A 27-point drop is significant.

The exact reprice will depend on the investors, the company’s growth profile, cash flow, margins, pipeline, and the market. But the company should expect meaningful downward pressure. A reduction in the low-to-mid 20s or 30s of the pre-money valuation is plausible, and perhaps more if investors demand a lower multiple.

For illustration:

* If investors apply 10x to corrected ARR of $10.5M: $105M pre.
* If investors apply 15x to corrected ARR of $10.5M: $157.5M pre.
* If investors apply 10x to post-non-renewal ARR of $9.55M: $95.5M pre.
* If investors apply 15x to post-non-renewal ARR of $9.55M: $143.3M pre.

These are not recommendations. They are illustrations of why the valuation conversation will be difficult.

### C. Delay, reprice, or restructure: what best protects the company

The company should not choose among these as if they are interchangeable. Legally, the first step is correction. Commercially, the company can then choose among delay, reprice, or restructure.

#### Delay

Delay alone does not cure the legal problem. But a short, controlled delay may be useful if:

* investors need time to reassess;
* the company needs time to negotiate a reprice;
* the non-renewal may be renegotiated;
* the $1.1M contract may go live;
* the round cannot be restructured in 12 days.

But delay should not be used as a stalling tactic to keep the old valuation. The corrected disclosure must go out now.

#### Reprice

A reprice may be the best commercial path if the investors still want the deal but not at $220 million pre. A reprice based on corrected metrics and full disclosure is legally cleaner than proceeding on the old terms.

The reprice should be negotiated openly, with all investors receiving the same corrected information. The company should avoid side deals that favor the anchor or the founder.

#### Restructure

A restructure may be best if the investors will not pay the old valuation and the company needs to preserve the round. Options include:

* reducing the round size;
* splitting the round into tranches;
* adding milestones tied to ARR, go-live, or customer replacement;
* using earnouts or valuation adjustment mechanisms;
* adding investor protective provisions;
* adjusting the founder secondary or pulling it;
* providing a bridge or convertible note if equity terms are too far apart.

A restructure can protect the company if the core problem is valuation, not investment interest. But it still must be built on corrected disclosure.

### D. Recommended commercial posture

The best protection is a combination:

1. **Correct immediately.**
2. **Suspend closing and the secondary.**
3. **Remediate the anchor.**
4. **Negotiate a reprice or restructure with the $32 million investors.**
5. **Use delay only if needed to complete the reprice/restructure.**

The company should not sign on the old terms to avoid a difficult conversation. The legal and reputational cost of proceeding on a misleading deck likely exceeds the cost of a lower valuation or a delayed round.

---

## 9. A concrete 48-hour plan for counsel

The following plan assumes the board meets in two days. Counsel should move quickly, but investor communications should be made under board authorization or at least board-chair authorization followed by ratification.

### Step 1: Immediate preservation and freeze — first 2 hours

1. **Issue a litigation hold.**  
   Preserve:
   * all versions of the deck;
   * all investor communications;
   * the CFO email;
   * data room materials;
   * financial workpapers;
   * ARR and NRR calculations;
   * the customer non-renewal notice;
   * subscription agreement;
   * term sheet;
   * board materials;
   * emails and chats among CEO, CFO, founders, investors.

2. **Freeze investor communications.**  
   Instruct management:
   * do not send further investor decks;
   * do not hold investor meetings;
   * do not make oral assurances;
   * do not characterize the old metrics as “just a definition”;
   * route all investor communications through counsel.

3. **Freeze the founder secondary.**  
   No founder share transfers until counsel and the board determine that disclosure conditions are satisfied.

4. **Run a conflict check and engage separate counsel.**  
   The company’s counsel may not be able to represent the CFO, CEO, founder, and company simultaneously. Separate counsel should be recommended for:
   * CFO;
   * CEO, if there is potential personal exposure;
   * founder;
   * board, if independent counsel is appropriate.

### Step 2: Verify the numbers and draft corrected disclosure — next 6 to 12 hours

1. **Meet with the CFO and controller.**  
   Obtain a written confirmation of:
   * standard recurring ARR of approximately $10.5M;
   * the $2.6M one-time fees;
   * the $1.1M signed-but-not-live contract and its termination right;
   * full-cohort NRR of 111%;
   * the two largest lost accounts excluded from the 138% figure;
   * the non-renewal notice and its ARR impact;
   * whether any other material metric is affected.

2. **Draft the corrected disclosure package.**  
   Include:
   * stand-alone correction letter;
   * revised deck;
   * ARR bridge;
   * NRR bridge;
   * non-renewal disclosure;
   * updated financial summaries;
   * meaningful cautionary language;
   * supersession language for the old deck.

3. **Prepare the anchor remediation options.**  
   Draft:
   * anchor correction notice;
   * offer of rescission and refund;
   * alternative amendment with price adjustment and release;
   * release form.

4. **Prepare board materials.**  
   Include:
   * legal risk memo;
   * corrected disclosure draft;
   * proposed board resolutions;
   * recommended next steps;
   * summary of exposure by party.

### Step 3: Executive session and emergency board preparation — hours 12 to 24

1. **Meet with the board chair or key independent directors.**  
   Explain:
   * the legal exposure;
   * why the CEO’s proposal is unsafe;
   * the need to suspend signing;
   * the need to correct the anchor;
   * the need to freeze the secondary.

2. **Schedule an emergency board session if possible.**  
   If the full board cannot meet within 24 hours, obtain chair authorization for:
   * litigation hold;
   * communication freeze;
   * suspension of closing;
   * secondary freeze;
   * preparation of corrective communications.

3. **Meet with the CEO and CFO.**  
   Document:
   * what they knew and when;
   * who approved the deck;
   * whether the CFO email was known to others;
   * who knew of the non-renewal notice before yesterday.

   Require cooperation with the corrective process. Advise them not to communicate independently with investors.

4. **Finalize the corrected disclosure.**  
   Ensure the corrected package is:
   * complete;
   * specific;
   * not misleading;
   * clearly marked as superseding prior materials.

### Step 4: Board meeting and resolutions — by hour 48

The board should adopt resolutions in the following order:

#### Resolution 1: Litigation hold and investigation

* Direct the company to preserve all relevant documents.
* Direct counsel to assess the facts and legal exposure.
* Authorize an internal investigation of the ARR, NRR, and non-renewal disclosures.

#### Resolution 2: Find prior materials misleading and direct correction

* Determine that the prior Series B materials containing ARR of $14.2M and NRR of 138% were materially misleading.
* Direct that the prior deck not be used.
* Direct that a corrected disclosure package be prepared and delivered to investors.

#### Resolution 3: Suspend signing and closing

* Suspend execution of any subscription agreements.
* Suspend closing of the Series B financing.
* Direct that no investor be induced to sign based on the prior deck.

#### Resolution 4: Freeze the founder secondary

* Suspend the founder’s proposed $4 million secondary sale.
* Direct that no secondary shares be transferred until corrected disclosure, investor acknowledgment, and board-approved conditions are satisfied.

#### Resolution 5: Approve corrected disclosure

* Approve the corrected disclosure package.
* Authorize counsel to deliver it to all investors.
* Direct that all prior materials be marked as superseded.

#### Resolution 6: Authorize anchor remediation

* Authorize counsel to notify the anchor investor of the corrections and the non-renewal.
* Authorize the company to offer:
  * rescission and refund, or
  * an amended subscription with corrected terms, price adjustment, and release.
* Direct that no anchor-related closing occur without written resolution of the anchor’s position.

#### Resolution 7: Direct reprice or restructure negotiations

* Authorize management and counsel to negotiate a reprice, restructure, or delay based on corrected metrics.
* Direct that no final terms be agreed until all investors have received the corrected disclosure.
* Direct that any founder secondary be priced consistently with the corrected valuation.

#### Resolution 8: Address conflicts and independent oversight

* Direct that the CEO, CFO, and founder obtain separate counsel if their interests differ from the company or board.
* If appropriate, direct that disinterested directors or an independent committee handle matters involving the CEO, CFO, or founder.
* If the founder is a director, direct that the founder recuse from decisions regarding the secondary and management liability.

#### Resolution 9: D&O insurance and claims evaluation

* Direct counsel to review the D&O policy for notice requirements.
* Direct counsel to evaluate whether any notice should be given, while recognizing the fraud exclusion.
* Direct that the company not rely on indemnification or insurance for fraud-based exposure.

### Step 5: Anchor remediation — immediately after board authorization

1. **Send the anchor a written correction.**  
   The letter should state:
   * the prior ARR and NRR figures were nonstandard and materially misleading;
   * the corrected ARR is approximately $10.5M;
   * the corrected NRR is 111%;
   * the company received a non-renewal notice from its second-largest subscription customer, representing approximately 9% of subscription revenue;
   * the company is correcting all materials before further closing.

2. **Offer two clean paths.**

   **Path A: Rescission**
   * Return $8 million, plus interest if appropriate.
   * Cancel the anchor’s subscription.
   * Obtain a mutual release.

   **Path B: Continue on corrected terms**
   * Amend the subscription agreement.
   * Update representations and disclosure schedules.
   * Adjust the price or allocation if necessary.
   * Obtain a release for pre-correction claims.

3. **Do not rely on correction alone.**  
   If the anchor wants to stay, require a release. Without a release, the anchor’s potential claims remain.

### Step 6: Corrected disclosure to the $32 million investors

1. **Deliver the corrected disclosure package.**  
   Send to all investors associated with the $32 million:
   * corrected deck;
   * correction letter;
   * ARR and NRR bridges;
   * non-renewal disclosure;
   * updated financials;
   * specific cautionary language.

2. **Replace the data room.**  
   Mark the old deck as superseded. Do not delete the old materials. The CFO email should remain available if already in the data room.

3. **Require written acknowledgment.**  
   Ask each investor to confirm receipt of the corrected disclosure before signing.

4. **Condition signing on corrected terms.**  
   No subscription agreement should be signed on the basis of the old deck.

### Step 7: Secondary decision

The board should treat the secondary as frozen.

It may proceed only if:

1. all buyers have received the corrected disclosure;
2. the anchor has been remediated or is no longer a buyer;
3. the secondary price reflects the corrected valuation;
4. the board has approved the secondary through disinterested directors or an independent committee;
5. the founder has separate counsel;
6. no buyer is receiving the nonpublic information selectively.

If any of those conditions cannot be met before closing, the secondary must be pulled.

### Step 8: Repricing/restructuring decision point

After the corrected disclosure is delivered, counsel should set a decision point for the next 24 to 72 hours:

* If investors accept corrected metrics at a reprice, proceed to amended terms.
* If investors require more time, consider a short delay.
* If investors reject the round, evaluate:
  * reducing the round;
  * bridge financing;
  * convertible note;
  * alternative investors;
  * restructuring the use of proceeds.

The company should not sign on the original terms to avoid this decision.

---

## 10. Final recommendation

The company should not sign on the CEO’s proposed schedule using the old deck. The legally correct course is:

1. **Preserve documents and freeze investor communications.**
2. **Verify and correct the ARR, NRR, and non-renewal disclosures.**
3. **Suspend signing and the founder secondary.**
4. **Remediate the anchor investor through rescission or an amended subscription with release.**
5. **Deliver complete corrected disclosure to the $32 million investors before signing.**
6. **Negotiate a reprice or restructure based on the corrected metrics.**
7. **Protect the board by documenting good-faith corrective action and, if necessary, using independent counsel or a special committee.**

The CEO’s “fix it for Series C” approach converts a painful valuation conversation into a potential fraud problem. The company can still save the round, but only by correcting the record now and negotiating from a place of accuracy rather than concealment.